Podcasts about Clinical

Send us Fan MailWhen is surfactant "early," and when is it too early, or too late? In this second installment of our two-part series with the Neonatal Resuscitation Symposium, Ben Courchia sits down with Dr. Roger Soll, a leading voice in surfactant research since the 1980s, to trace how our thinking on timing has evolved, from aggressive prophylactic dosing to selective rescue therapy to today's less invasive approaches like LISA and SALSA. Dr. Soll unpacks why head-to-head trials keep favoring less invasive administration over InSurE, and how the rise of "nanopreemies" is quietly pulling the pendulum back toward earlier treatment. The conversation also touches on video laryngoscopy and aerosolized surfactant's unfulfilled promise. A candid, technically rich conversation for anyone who has stood at a warmer wondering whether, and when, to reach for surfactant. Dr. Soll expands on these themes at the Neonatal Resuscitation Symposium, September 10 to 11, 2026, at Indiana University School of Medicine. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss the numerous attempts by states to roll back vaccine laws, the recent surge of Dengue virus cases in Sri Lanka, the national cyclospora outbreak, new screwworm and Legionnaires cases, launching of the CHaT-Ox Ebola vaccine trail, scale of the Ebola outbreak in the Congo and if cross-reactive Ebola antibodies are effective, before Dr. Griffin deep dives into the measles outbreak including the new Pennsylvania dashboard, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how to access and pay for Paxlovid, where to go for answers about long COVID-19, how long COVID and ME/CFS differ and contacting your federal government representative to stop the assault on science and biomedical research.   Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Dozens of States Tried to Roll Back Vaccine Laws. Here's How They Fared. (NY Times) Dengue cases in Sri Lanka surge past 80,000 (Newswire) After withdrawing false-positive test, FDA says Taylor Farms lettuce still a focus of Cyclospora investigation (CIDRAP) A difficult-to-trace parasite, messaging missteps contribute to summer of overwhelming Cyclospora outbreaks (CIDRAP) Surveillanceof Cyclosporiasis (CDC: Cyclosporiasis) Infectious DiseaseOutbreaks (Michigan: Health & Human Services) Cyclosporiasis Cases in North Carolina (North Carolina: Division of Public Health) Cyclospora Infection (Cyclosporiasis) (NYC Health) Legionnaires' Disease (NYC Health) MAP UPDATE: 50 buildings in Manhattan outbreak zone test positive for live bacteria (NBC: News) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Ebola dashboard (ebola.fyi) EBOLA:The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial (University of Oxford) Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines (NEJM) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) HAP's Latest News Pa. Launches New Measles Dashboard (Hospital + HealthSystem Association of Pennsylvania) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Impact of Nirsevimab in Its Second Season on Respiratory Syncytial Virus and Non-RSV Admissions in Children Under 5 (Pediatric Infectious Disease Journal) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Remdesivir and All-Cause Graft Loss Among Kidney Transplant Recipients With Symptomatic COVID-19 (JAMA: Network Open) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) Skeletal muscle properties in long COVID and ME/CFS differ from those induced by bed rest (Nature Communications) Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms (eBioMedicine) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1344 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Send us Fan MailWhich babies with critical congenital heart disease face the highest risk of brain injury, and does earlier surgery actually help? Why is infant CHD mortality climbing again after years of decline, and who's most affected? Can a mother's cardiovascular status in preeclampsia predict her newborn's circulatory transition? This week's Journal Club brings together five conversations on CHD, maternal-fetal physiology, and vaccine policy. Nim and Adrianne cover a meta-analysis on brain injury in critical CHD, a 25-year national mortality study, a pilot study on preeclampsia and neonatal cardiac output, and a look at RV diastolic function after CHD intervention. Ben and Eli close with Neo News on a controversial hepatitis B vaccine trial in Guinea-Bissau.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

In this episode, Dr. Maulik Purohit, Chief Health Innovation Officer at datosX Digital Health Labs, discusses the rapid evolution of digital health, why clinicians must remain central to AI-supported decision making, and how leaders can foster trust and collaboration when technology and human expertise diverge.

This episode was planned to meet the educational needs of critical care pharmacists by increasing their awareness of the prevalence of opioid use disorder, common challenges encountered in managing pain control and sedation in patients with opioid use disorder, and how to implement best practices in this patient population. CE for this episode expires 2 years after the date it was originally published. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Can artificial intelligence restore humanity to my patient interactions? In this episode, Dr May Lin and Dr Brent Sugimoto explore how ambient scribing and smarter administrative tools free physicians to be truly present with their patients, allowing technology to become a bridge in patient care rather than a barrier. Our guests also tackle the ethical and policy dimensions of how AI affects family medicine in both the exam room and the classroom. They identify the current moment as an opportunity for residency programs to shape how AI is used in family medicine, emphasizing that if today's residents are not trained to use AI tools ethically and wisely, their future patients may miss out on the benefits of technology-assisted care.Hosted by Omari A. Hodge, MD, FAAFP and Jay-Sheree Allen Akambase, MDCopyright © Society of Teachers of Family Medicine, 2026Resources:Blood in the Machine: The Origins of the Rebellion Against Big Tech by Brian MerchantArtificial Intelligence and Machine Learning for Primary Care Curriculum (AiMPC) CourseEthical Use of AI in the Family Medicine Clinic - STFM WebinarAn Opportunity to Thrive - AI in Family Medicine - STFM PodcastAI Deep Dive Summer Series Episode 1: Integrating AI into Family Medicine Curriculum Design - STFM PodcastAI Deep Dive Summer Series Episode 2: The Promises and Pitfalls of AI in Residency Assessment - STFM PodcastGuest Bio:May Lin, DODr Lin is board certified in Family Medicine and Osteopathic Manipulative Medicine (OMM). She practices at Amazon/One Medical where she also serves as the Director of Academic Development. A graduate of Harvard Medical School's Executive Education Course on AI in Healthcare, Dr. Lin serves on the American Association of Colleges of Osteopathic Medicine's (AACOM) Technology Task Force, Touro University's AI Task Force, and the American Osteopathic Information Association's (AOiA) national steering committee. As an Osteopathic Health Policy Fellow, Dr. Lin blends policy interest with leadership experience in healthcare technology and medical education. Dr. Lin is passionate about advancing medical innovation giving patients increased access, decrease cost and improved quality in high touch, technology forward medical care. Integrating primary care, medical innovation, healthcare technology, and healthcare policy are key attributes to supporting primary care and elevating our next generation for sustainable primary care practice and delivery.Brent Sugimoto, MD, MPHDr Sugumoto is program director of the LifeLong Medical Care Family Medicine Residency Program and a Family Physician who specializes in HIV medicine. He currently serves as co-chair of the AAFP/Rock Health “Advancing AI and Digital Health for Primary Care Initiative.” Brent ventured into artificial intelligence after the birth of his first child—when parenthood made him rethink the boundaries of his professional and personal lives—and co-founded a startup called Decoded Health, which leveraged technology from DARPA to build tools to make primary care sustainable. Since then, Brent has worked to increase family medicine's engagement in AI/ML as a potentially transformative and disruptive technology through physician education and policy work within the specialty. Brent is excited to be a member of this task force, as he believes health technology literacy will be a critical competency for future family physicians. He uses ambient scribing with moderate success in his own practice.Link:https://www.stfm.org/stfmpodcast082026 

In this episode, Dr. Jeffrey brings us an extraordinary case with an incredible diagnostic twist that will keep you on the edge of your seat until the very end. Follow along as we unravel the clues and see where the clinical reasoning leads. To join us live on Virtual Morning Report (VMR), sign up HERE.… Read More »Episode 468 – The Clinical Unknown Series with Dr. Jeffrey Shen

Send us Fan MailIn this episode of Neo News, Ben and Eli break down a troubling story in vaccine policy: an unsolicited $1.6 million CDC grant funding a Danish research group's trial in Guinea-Bissau, one designed to withhold or delay the hepatitis B birth dose from thousands of newborns in a country where the disease is highly endemic. They trace the ethical parallels to Tuskegee, the funding irregularities, and the pushback from the Africa CDC that halted the study. They also cover the clinical stakes clinicians face daily, including age-dependent chronicity and the real risks of a "safe" two-month delay. A candid, unfiltered conversation about advocating for evidence-based care when the evidence itself becomes politicized.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

As healthcare continues its transition toward value-based care, clinical decision support (CDS) is becoming an essential tool for improving appropriate utilization while reducing administrative burden. On this episode, guest hosts Dr Sandy Rolfe (Optum, WEDI Genomics Workgroup) and Julie Brown-Georgi (AMA, WEDI's Value-Based Care Workgroup) interview Rachael Hulshizer from Mayo Clinic and Elizabeth Zobel from CareSelect® Lab to discuss how EHR-integrated, point-of-order CDS is transforming laboratory and genomic test ordering through evidence-based guidance, interoperability standards, and actionable analytics. The conversation explores how structured data, FHIR-enabled exchange, and clinician-centered workflows can help advance stewardship, improve patient care, and support the future of precision medicine

The government is walking us toward the biggest announcement in human history ... a hearing here, a report there, a file at a time. Clinical psychologist Dr. Jennice Vilhauer says we're getting the truth with no instructions. She joins Dr. Phil to explain why disclosure isn't an information problem but a human one, who's most at risk when it lands, why witnesses have been misjudged for seventy years, and why "we'll be fine" is not a plan.Thank you to our sponsor:Retirement Ready? Get up to $20,000 in FREE Gold & Silver with a qualified purchase. Text ASKPHIL to 50505 or visit https://DrPhilgold.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Let's cut through the noise....If someone you loved needed pelvic floor therapy tomorrow, where would you send them?

Send us Fan MailIn this prospective study, Adrianne and Nim dig into an area with almost no normative pediatric data: right ventricular diastolic function. Comparing 57 infants with RV pressure overload after intervention for pulmonic stenosis or tetralogy of Fallot to 134 healthy controls, the authors found a consistent pattern, reduced beat-to-beat variability, a higher atrial contribution to filling, and an E/A ratio inversion that was nearly universal in the CHD group versus about half of controls. It's one of the first real attempts to define what a right-sided diastolic pattern actually looks like in this population. But without a comparison against cardiac catheterization, the hosts agree the findings are hypothesis-generating at best, a starting point for a multi-parametric approach, not a reason to skip an invasive workup.----Echocardiographic Markers of Right Ventricle Diastolic Dysfunction in Neonates and Infants with Congenital Heart Disease. Cantinotti M, Capponi G, Scalese M, Palladino E, Giordano R, Franchi E, Viacava C, Corana G, Marchese P, Pizzuto A, Assanta N, Santoro G. J Clin Med. 2025 Dec 23;15(1):98. doi: 10.3390/jcm15010098. PMID: 41517351 Free PMC article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

ReferencesProc Natl Acad Sci U S A. 2004 Jul 28;101(32):11803–11808.International Urogynecology Journal (2020) 31:1495–1496Sci Rep. 2022 May 18;12(1):8289.Guerra, DJ.2026. Unpublished LecturesZappa, F. 1966. You're Probably Wondering Why I'm here. Mothers of Invention. Freak Out.lphttps://open.spotify.com/track/6K7nz8CasqgyDGnkZOZuw8?si=ce2e3d2358d041c2

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Biogen has made a significant acquisition by purchasing Apellis Pharmaceuticals, a move expected to boost its 2026 revenue guidance with promising growth prospects. This strategic acquisition, along with strong sales from new drugs, enhances Biogen's position in the competitive market for neurological disorders. By integrating Apellis' offerings, Biogen is poised to strengthen its portfolio, particularly in areas of unmet medical need. On the regulatory front, AbbVie has achieved a milestone with its drug Rinvoq (upadacitinib), which has received dual approvals from the European Union for treating non-segmental vitiligo and severe alopecia areata. These approvals were based on successful Phase 3 data, underscoring Rinvoq's efficacy as a JAK inhibitor in tackling autoimmune conditions. This development not only highlights AbbVie's commitment to expanding its therapeutic portfolio but also positions upadacitinib as a potential mainstay treatment for dermatological autoimmune diseases. AstraZeneca Pharma India has secured approval from the Central Drugs Standard Control Organization for Enhertu (trastuzumab deruxtecan) in the neoadjuvant setting for HER2-positive early breast cancer. This approval marks a significant advancement in personalized cancer therapy, offering new hope for patients with this aggressive form of breast cancer. In terms of industry collaborations, the landscape is witnessing numerous partnerships and strategic alliances that are driving innovation forward. Skyverna Therapeutics and ElevateBio have entered a five-year clinical and commercial supply agreement for autoimmune CAR-T therapy, reflecting the growing interest in cell therapies for rare diseases. Meanwhile, Vertex Pharmaceuticals and AbCellera have joined forces to accelerate drug discovery in autoimmune T-cell engagement, supported by a $28 million upfront investment. These collaborations emphasize the importance of combining expertise and resources to advance complex therapeutic solutions. The integration of artificial intelligence in drug development continues to gain momentum. Evinova and Merck KGaA's strategic collaboration aims to leverage AI and machine learning to enhance clinical trials' efficiency, potentially ushering in a new era of precision medicine. Such partnerships highlight the transformative potential of AI in streamlining research and development processes. In funding news, Core Biomedicine has secured $21 million in Series A financing to advance its precision oncology therapeutics. Enlivex's substantial $400 million private placement aims at advancing prediction markets treasury and Allocetra immunotherapy, further accentuating the focus on personalized medicine targeting specific cancer pathways. Clinical trials have also delivered promising results. ProMIS Neurosciences reported positive interim safety and biomarker data from its Phase 1b study of PMN310 for Alzheimer's disease. This monoclonal antibody targets amyloid-beta oligomers implicated in Alzheimer's pathology, offering hope for patients with this debilitating disorder. Mergers and acquisitions remain active, exemplified by Caldera Therapeutics' reverse merger with Synlogic alongside $278 million in financing to advance its bispecific antibody for inflammatory bowel disease. This move reflects a broader trend toward consolidating resources to tackle complex autoimmune conditions. Eli Lilly's ascent to the top of Norstella's pipeline-to-patient productivity index is noteworthy, driven by successful launch strategies and rapid development cycles. This achievement underscores Eli Lilly's effective alignment of R&D efforts with market needs, particularly in areas such as GLP-1 receptor agonists that have transformed diabetes care. Teva Pharmaceuticals is demonstrating resilience through its innovative medicines portfolio amidst declining generic sales. The unexpected surge in Ajovy sales highlights Teva's pivot toward high-value branded drugs amidst competitive pressures. Novo Nordisk faces legal challenges as it navigates allegations regarding Cagrisema's Phase 3 study protocol changes. Legal scrutiny around transparency in clinical trial disclosures continues to highlight the importance of ethical practices and investor trust. Collectively, these developments illustrate a vibrant yet challenging environment where scientific advancements in immunotherapy and targeted treatments intersect with strategic business alignments focused on sustainable growth. As these trends unfold, they promise more effective treatments for complex diseases while companies adapt to an evolving market environment demanding agility and foresight. As always, stay tuned to Pharma Daily for more insights into how these transformations continue to shape the future trajectory of drug development and healthcare delivery globally.Support the show

A clinical neuroscientist breaks down the two things that actually make you happy, a quest and a crush, and the brain science behind why a little whimsy is so good for you. Dr. Caroline Leaf sits down with her daughter and producer Dominique to unpack Dominique's theory of happiness: to feel happy, you need a quest and a crush. It sounds playful, but the neuroscience runs deep. Dopamine, norepinephrine, serotonin, cortisol, theta waves, and the resilience networks that form every time you choose a bit of whimsy over the grind. If you have felt flat, stuck in hustle mode, or like the fun drained out of ordinary days, this one is for you. It is a warm, funny, science-backed conversation about how to be happy again by bringing whimsy back on purpose. What you'll learn:- Why a quest and a crush flip your brain into its healthiest, most efficient state- What actually happens in your brain and body when you have a crush (dopamine, norepinephrine, and those butterflies)- Why early infatuation shows serotonin levels that look almost identical to OCD, and why that is completely normal- How to read anxiety as useful data when a quest starts to tip from healthy toward toxic- Why your mind is in charge and your brain carries out its instructions, and what that means for how you feel- How small whimsical moments wire lasting resilience into your brain- Simple ways to turn errands and mundane days into a quest Resources:Dr. Leaf's Website: https://drleaf.comNeurocycle Certification, Clinical: https://drleaf.com/clinical-certificationNeurocycle Certification, Strategist: https://drleaf.com/certified-strategist1:1 Coaching with Dr. Leaf: https://drleaf.com/coaching-1-1Neurocycle App: https://drleaf.com/neurocycle-app Support the sponsors:-Veracity, up to 65% off GLP-1 support: VeracityHealth.co (code DRLEAF) (edited)  -OSEA, 10% off your first order sitewide: OSEAMalibu.com (code LEAF) -Shopify, start your free trial: shopify.com/leaf Subscribe so you don't miss the next one. New episodes every Wednesday.What is one quest or one crush you could give yourself this week? Tell me in the comments.

Send us Fan MailIn this small prospective pilot study, Adrianne and Nim explore a domain rarely discussed on rounds, how a mother's cardiovascular function in preeclampsia shapes her newborn's circulatory transition. Using maternal echo and neonatal electrical cardiometry across 13 mother-baby dyads, the authors found an inverse relationship: the worse the mother's cardiac function, the higher the neonate's cardiac output, though vascular tone barely budged. It's a compelling hypothesis about placental strain and fetal adaptation. But Nim pushes back hard on the methodology, pairing this paper with a companion study showing electrical cardiometry consistently overestimates cardiac output in neonates, and questioning why daily echoes were performed on these babies but the results never reported.----Linking maternal and neonatal circulation in preeclampsia. Piani F, Annesi L, Degli Esposti D, Vincenzi S, De Crescenzo S, Della Gatta AN, Simonazzi G, Corvaglia L, Martini S.Am J Physiol Heart Circ Physiol. 2026 Mar 1;330(3):H708-H716. doi: 10.1152/ajpheart.00945.2025. Epub 2026 Jan 12.PMID: 41525138 Free article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Shaju Puthussery and Deepak Ramaswamy are the CEO and CTO of LightSpun, which is rebuilding the back-end engine of insurance processing as agentic AI infrastructure, starting in dental and moving into vision and ancillary benefits. Both came from Overjet, where Deepak was a co-founder and Shaju the first employee, and this conversation is largely about why they walked away from that thesis. Reading X-rays was the visible AI problem. Underneath it was a plumbing problem: claims that never reach clinical review because the documents were wrong, the provider record did not match, or the file never loaded cleanly.Two things in this episode surprised us. The first is that their most valuable asset was an accident. Shaju assumed credentialing was table stakes until a payer CEO told him it was blocking dentist onboarding, and one weekend later Deepak had an approach. That became the rail for roughly 87% of practicing dentists in the US and the provider data spine that feeds adjudication. The second is Shaju's answer to whether anyone profits from claim friction, which is not the cynical answer most people give.We discuss:Why Deepak argues the AI question is not either-or, and why world-class clinical review is worthless if the claim cannot get to itThe moment their business model was confidently wrong: they built for benefits configuration, customers came back asking about credentialing, duplicate records, and file loads, and a startup that planned to do one thing had to bet on tenWhy credentialing was never a Trojan horse for the provider data layer, how the same 200,000-dentist dataset gets monetized twice, and what obligation comes with being the thing the system quietly depends onThe honest ceiling on model performance: 85 to 90% out of the box, and why the climb to 98 or 99% production-ready is where the humans actually liveThe exact decision they will not automate, with the line drawn between deterministic denials (two cleanings a year, a $2,000 annual max) and anything touching a clinical outcomeWhy regulation, not technology, sets the pace, and how they take a faster primary source verification method to their internal NCQA leader with screenshots, timestamps, and source authenticity to prove it still holds upShaju's contrarian read on the $17 to $21 billion admin waste question: no one is winning from the friction, both sides are automating, and the real goal is shifting dollars from admin to careBringing fintech into adjudication with a benefits flex card that carries a Visa or Mastercard rail, blocks non-covered procedures at the chair, and opened doors to a vendor network of roughly 150 health plansThe discipline of not chasing every model release, what Hugging Face taught them early about picking bets, and why the architecture is built to swap foundation models out entirelyDeepak's pushback on the beachhead narrative: dental is several years behind medical, which means the solutions may not transfer cleanly, and they designed for vision and ancillary from day one rather than treating dental as a waypointWhy compliance came before the AI story, with SOC 2 Type 2, HITRUST, and NCQA in place first so they could get in the room with large payers at allThe legacy Deepak actually wants: recognized as the company that automated the boring and the safe, and left the critical decisions with people—Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations.—Where to find Jared:• X: https://x.com/jaredstaylor• LinkedIn: https://www.linkedin.com/in/jaredstaylor/

MEDICARE ADVANTAGE MINUTE:                                                                         IN A HEALTHY YEAR A MEDICARE ADVANTAGE YEAR CAN SAVE YOU $2640. IN A CANCER YEAR IT CAN COST YOU $9250. SUSIE HAS FRIENDS THAT PURCHASED EXPENSIVE PLAN G RATHER THAN MY RECOMMENDED, MUCH LESS COSTLY HIGH DEDUCTIBLE PLAN G.                      HER FRIENDS TURN OUT TO BE CONTOL FREAKS! MY FRIEND BOB'S WIFE HAS A PDP (PRESCRIPTION DRUG PLAN) THAT CHANGED THE COVERAGE OF SOME DRUGS IN ITS FORMULARY FROM LAST YEAR TO THIS. AN OBJECT LESSON TO THOSE WHO DO NOT PERFORM AN ANNUAL SEARCH FOR THE MOST ADVANTAGEOUS PLAN AVAILABLE IN THE FOLLOWING YEAR. LONG-TIME LISTENER STEVE INADVERTANTLY CAUSED A CORRESPONDENT TO CHASTISE HIM FOR USING THE WORD "RETARD" IN A SELF-DESCRIPTIVE WAY. TALK ABOUT WOKE!                                                                                                  STEVE ALSO DESCRIBED A MARMITE ENCOUNTER THAT RESULTED IN AN APOLOGY WITH THE PROMISE OF A GIFT OF TASTY BRITISH BEER AS A SIGN OF CONTRITION.  FINALLY, LONG-TIME LISTENER DOMINICK DISCLOSED A LIST OF THE TEN WORST STATES IN WHICH TO LIVE. AFTER REALIZING THAT EACH PLACE ON THE LIST VOTED OVERWHELMINGLY CONSERVATIVE, DOUBT HAS BEEN CAST ON THE CNBC LIST CONSTRUCTORS! Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2026; SIMPLEST & EASIEST GUIDE EVER!" "MEDICARE ENROLLMENT GUIDE" - DOWNLOAD FREE "MEDICARE DRUG PLANS: A SIMPLE D-I-Y GUIDE" ....AND A PODCAST! @ DBJ@M4TLM.com W medicareforthelazyman.com T (630) 878-5055   Review Us On Google  For sale on Amazon.com. After enjoying the books, please consider returning to leave a short customer review to  help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Shyun Patel joins Payman as a final-year dental student at Liverpool, best known for founding BDSA, the biggest undergraduate dental conference the UK has seen, and for buying his own practice before he's even qualified.He talks candidly about losing the Dental Society presidency election, the autoimmune diagnosis that reshaped how he thinks about time, and the fridge-flipping side hustle that helped fund his first practice.This is also a conversation about ambition and its cost. From the cathedral gamble that saved BDSA's gala dinner to the balance between depth and breadth of impact, Shyun's reflections on business are as sharp as his reflections on himself.Expect thoughtful exchanges on hubris, communication as a clinical skill, sacrifice, and what it means to build something at 23 that most people wait decades to attempt.In This Episode00:00:50 – Introduction00:01:30 – Growing up in Liverpool00:06:14 – Communication vs skill00:08:36 – Teaching communication00:14:00 – Public misconceptions00:22:38 – Hubris00:22:52 – Insecurity and upbringing00:32:57 – Losing DentSoc presidency00:41:20 – Autoimmune diagnosis00:50:07 – Building a dating app00:58:00 – Business by osmosis01:01:26 – The value of asking01:04:32 – Scale of BDSA01:07:26 – Funding BDSA01:17:07 – Leadership and delegation01:21:00 – Sales and sponsorship01:25:10 – The cathedral gamble01:29:47 – The fridge hustle01:41:07 – Ambition and sacrifice01:47:43 – Blackbox thinking01:52:41 – Clinical vs business01:59:35 – Depth vs breadth02:01:11 – Heroes and resources02:05:29 – Fantasy dinner party02:07:31 – Five-year visionAbout Shyun PatelShyun Patel is a final-year dental student at the University of Liverpool and the founder of BDSA, the largest undergraduate dental conference staged in the UK to date. Alongside his studies he already owns a dental practice, works as a dental rep for Bryant, and is building a compatibility-focused dating app in his spare time.

Finding the right therapist can feel overwhelming. Beyond credentials, specialties, and availability, many people find themselves asking another important question:Does race matter when choosing a therapist?For some, the answer is an immediate yes. For others, it's not a deciding factor. The truth is, there isn't a universal answer because therapy is deeply personal. What helps one person feel safe and understood may not be what another person needs to begin healing.In this episode of Therapy, Trust & Identity, we explore the complex relationship between race, culture, trust, and the therapeutic alliance. Rather than telling you who you should choose, this conversation encourages thoughtful reflection about what helps you feel seen, heard, and supported throughout your mental health journey.Thanks for reading The Rooted Productions™! This post is public so feel free to share it.Why This Conversation MattersMental health care isn't one-size-fits-all. Every person enters therapy with a unique story shaped by culture, family, identity, faith, lived experiences, and personal values.For many Black and Brown communities, historical mistrust of healthcare systems, cultural stigma surrounding mental health, and experiences with discrimination can influence how comfortable someone feels opening up in therapy.Representation matters—but it isn't the only thing that matters.While some people feel an immediate sense of safety with a therapist who shares their racial or cultural background, others have found life-changing healing with therapists whose experiences are very different from their own.The more important question may not simply be, “Do they look like me?” Instead, it becomes:“Can they truly understand me, respect my experiences, and create a space where I feel emotionally safe?”Questions We ExploreDuring this episode, we discuss several important questions:* Does race really matter when choosing a therapist?* What are people truly seeking when they say, “I want a therapist who looks like me?”* Can a therapist from a different race or culture still provide meaningful, effective support?* Is preferring a therapist of your own race protective, limiting, or something in between?* What ultimately matters most in therapy: feeling seen, feeling safe, feeling understood, or finding someone who helps you heal?These questions don't always have simple answers, but they open the door to meaningful conversations about identity, trust, and culturally responsive care.Beyond Shared IdentityHaving a therapist who shares your racial or cultural background can offer advantages such as shared cultural references, reduced need to explain certain experiences, and a greater sense of immediate connection.However, shared identity alone doesn't guarantee a strong therapeutic relationship.An effective therapist is someone who demonstrates empathy, cultural humility, clinical competence, active listening, and a willingness to understand your experiences without making assumptions.Likewise, a therapist from a different background can become an exceptional source of support when they approach your story with curiosity, respect, and a commitment to lifelong cultural learning.Healing often grows from trust—not assumptions.What Makes a Good Therapeutic Relationship?Research consistently shows that one of the strongest predictors of successful therapy is the therapeutic alliance—the trusting relationship between therapist and client.Ask yourself:* Do I feel emotionally safe during our sessions?* Can I speak honestly without fear of judgment?* Does my therapist respect my identity and experiences?* Do I leave sessions feeling supported and challenged to grow?* Am I making progress toward the goals that matter most to me?These questions may reveal more about whether you've found the right therapist than demographics alone.There Is No “Right” ChoiceChoosing a therapist isn't about passing a social test or proving a point.Some people intentionally seek therapists who share their identity.Others prioritize specialization, treatment approach, personality, faith, language, gender, or availability.Neither choice is inherently right or wrong.The goal is finding someone who helps you heal.If you don't feel connected with your therapist, it's okay to ask questions, discuss concerns, or even find someone who is a better fit. Therapy should be a place where you feel empowered—not obligated to stay in a relationship that isn't helping you grow.Join the ConversationI'd love to hear your perspective.What matters most to you when choosing a therapist?Is it shared identity?Clinical expertise?Feeling understood?Cultural competence?Or simply finding someone who creates a safe space for healing?Share your thoughts in the comments and let's continue this important conversation together.Continue the ConversationIf you enjoyed this discussion, don't forget to Like, Subscribe, and Share for more conversations about mental health, identity, healing, culturally responsive care, and personal growth.

In this throwback episode of the Very Clinical Podcast, hosts Zach and Kevin welcome Dr. Sully Sullivan from Nashville, Tennessee. Sully shares his journey of joining his father's successful dental practice and the strategic moves that propelled their exponential growth. From overcoming generational ego to investing in CBCT technology and executing a massive office expansion from 2,700 to 11,000 square feet, Sully breaks down the mindset required to scale. He also details the importance of feeding your associates first to ensure their success. Tune in for an inspiring conversation about pushing past entitlement, taking calculated risks, and building an unstoppable multi-provider practice. Some links from the show: 3D Dentists Join the Very Clinical Facebook group!  Join the Very Dental Facebook Group using one of these passwords: Timmerman, Paul, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, or Lipscomb!  The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! We're proud to be supported by the folks at Net32! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

Send us Fan MailIn this retrospective national study, Adrianne and Nim look at 25 years of congenital heart disease mortality in the US using CDC WONDER data. Infant mortality remains staggeringly high (54 per 100,000), and after years of steady decline, it has been climbing again since 2014. Disparities run throughout: higher deaths among males, non-Hispanic Black and American Indian/Alaska Native populations, and in rural, Midwestern regions, pointing more to gaps in access and resources than to disease biology. The conversation also flags a growing, under-discussed problem, an aging adult congenital population outpacing the pediatric one for the first time, with too few specialists trained to care for them.----National Trends and Disparities in Congenital Heart Disease Mortality in the United States, 1999-2024.Raja S, Albrahim MMS, Aldhafeeri BF, Omar AA, Alqadeeb BA, Alhuways MM, Bangaryd AA, Alqahtany MG, Alfaraj AB, Almughyir RS, AlRasheed ST, Alfaifi M. Pediatr Cardiol. 2026 Jan 13. doi: 10.1007/s00246-025-04156-1. Online ahead of print.PMID: 41528440Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Part 3: Creating the Conditions for Disclosure What makes disability disclosure feel safe, supported, and meaningful in healthcare? In the final episode of the Disclosureseries, we move beyond the barriers to examine the conditions that allow disclosure to lead to access, trust, and belonging. Through the perspectives of medical students, physician assistant students, fellows, physicians, and educators, this episode explores how institutional systems, responsive accommodations, inclusive leadership, and everyday acts of advocacy shape disclosure experiences across medical training and practice. Contributors reflect on the importance of flexible accommodation processes, proactive communication, faculty and peer support, and the role of community in fostering psychological safety. Together, these stories demonstrate that while policies create opportunities for access, people create the conditions for trust—and that building environments where disabled learners and clinicians can thrive ultimately strengthens healthcare for everyone. Featured Contributors Anonymous Physician Assistant Student Khaja Siddiqui Anonymous Medical Student Anonymous Fellow Dr. Andrea Lendaris Dr. Karla Castro-Frenzel Transcript https://docs.google.com/document/d/1vgn-NGI52buG-xXUxIOCBMhd3oM6Jyz-9W0KDP-KwG0/edit?usp=sharing Keywords Disability disclosure Disability accommodations Medical education Clinical accommodations Medical students with disabilities Residents with disabilities Healthcare workplace culture Psychological safety Faculty advocacy Inclusive leadership Accessibility in medicine Physicians with disabilities Health professions education Disability inclusion Healthcare culture Community and belonging Identity safety Production Team Developer, Writer, Executive Producer: Sofia Schlozman Co-Producers: Rylee Betchkal and Lisa Meeks Co-Producer, Sound Selection and Editing: Gabe Abrams Sound Production: Next Day Podcast Digital Media: Katie Sullivan

The Big Unlock · Umesh Rustogi, General Manager, HLS Dragon & Platform, Microsoft In this episode, Umesh Rustogi, General Manager, Healthcare & Life Sciences Dragon & Platform at Microsoft, explains that meaningful AI outcomes depend on combining unified multimodal data foundations with clinician-centered design to achieve healthcare’s quadruple aim: improving care quality, patient experience, operational efficiency, and workforce well-being. Addressing the severe nursing shortage and turnover driven by administrative burnout, Umesh details how Microsoft co-innovated with nine major health systems to deploy Dragon Copilot for Nursing, a clinical assistant that works alongside nurses. By leveraging ambient AI on mobile devices, the solution helps nurses capture flow sheet documentation for their review and maintains a running cognitive memory across shifts, significantly lowering cognitive load and enabling nurses to be truly present with their patients. Umesh also emphasizes that enterprise-scale success requires far more than model selection. It demands responsible AI governance, transparent audit capabilities, deep workflow customization, and robust change management, including nurse leader sponsorship and dedicated unit champions. He envisions smart hospital rooms, multimodal AI, wearable integration, and agentic workflows transforming clinical operations by delegating non-patient-facing tasks so caregivers can focus on delivering better care. Take a listen. This guest appearance was facilitated through conversations initiated at HIMSS.

HOST: Dr. Daina Parent, ND GUEST: Cheryl Cuozzo, MSN, APRN, ANP-C, FNP-C, FAIHM   Cheryl Cuozzo, an integrative Nurse Practitioner, shares her personal story overcoming Lyme Disease with host and Naturopathic Doctor Daina Parent. They discuss early signs and symptoms, issues with testing and protocols, and the limits of the conventional model when dealing with complex conditions such as Lyme, co-infections and other chronic conditions. Cheryl's inspiring story led her to design an integrative foundational healing program for her patients that she based of off the holistic care that helped her recover from Lyme. Both practitioners share diet, lifestyle, supplementation and herbal remedies that support the multisystem recovery process from complex conditions.   Cheryl Cuozzo, MSN, APRN, ANP-C, FNP-C, FAIHM, is a dual Master's–prepared clinician with graduate degrees in Nursing Education and Nurse Practitioner studies. She is double board-certified as an Adult and Family Nurse Practitioner and is a Fellow of the Academy of Integrative Health & Medicine (FAIHM). Cheryl is the first and only Nurse Practitioner in Connecticut to earn FAIHM distinction.  Cheryl's work emphasizes foundational nutrition, neuroimmune regulation, detoxification support, and whole-body lifestyle strategies. She is the founder of Intentional Wellness, a worldwide virtual consulting platform born from her Connecticut-based practice, Cuozzo Health Integrative Medicine. Having personally recovered from Lyme disease using integrative, non-drug approaches, her clinical focus centers on supporting individuals with Lyme disease, co-infections, and other complex, multisystem chronic conditions.   2:00 Cheryl's personal Journey with Lyme: early symptoms and signs 5:25 Cheryl's personal Journey with Lyme: Laboratory testing discrepancies and working Dr. Sensenig 10:28  Cheryl's personal Journey with Lyme: Navigating conventional and holistic strategies 13:15 Five Healing Foundations: integrative strategies as the foundation of Cheryl's practice, modeled after her own experience 18:30 The importance of whole food nutrition in the healing process 19:12 The importance of starting a detoxification/purification protocol with a qualified healthcare practitioner before incorporating strong herbs to address Lyme 24:05 Targeted movement and regenerative sleep as part of the healing process 33:54 Neuroimmune and Endocrine regulation 35:42 Herbal supplementation for energy and nervous system regulation 37:28 Toxic load reduction – through a focus on diet, personal and household care products, and detoxification/purification 42:26 Clinical tip: prescribing lifestyle and sleep recommendations to patients for greater compliance 45:21 Integrative care as a Nurse Practitioner: Differences between the conventional model and an integrative approach 49:22 Dr. Sensenig quote "The minute you reduce medicine to protocols you remove the patient from the equation" – looking at each person as an individual 50:03 Supplements and herbal remedies for neuroinflammation in Long COVID and EBV antibody reactivations 52:17 Supplementation and herbals for Lyme coinfections 54:09 Timeline for working with long COVID – when do patients start to feel better? 56:35 Cheryl's mentorship program - training other practitioners in whole food nutrition and integrative strategies: www.cuozzohealth.com 58:57 Shift from conventional mindset to integrative approach - "what's good for the patient?" 1:00:35 Not a one-size-fits-all strategy for Lyme, long COVID and coinfections; remembering the foundation of whole food nutrition

Immune checkpoint inhibitors have rapidly reshaped care for triple-negative breast cancer (TNBC)—but surgical teams increasingly encounter their downstream perioperative consequences. In this episode, we define immunotherapy through the lens of checkpoint biology, review the landmark evidence supporting pembrolizumab in metastatic PD‑L1–positive TNBC (KEYNOTE‑355) and curative-intent stage II–III TNBC (KEYNOTE‑522), and translate immune-related adverse events (irAEs) into practical periop recognition, triage, and timing decisions—especially for endocrine, pulmonary, hepatic, dermatologic, and GI toxicities. Hosts:- Rashmi Kumar, MD, PhDResident, University of Michigan General Surgery Residency Program Twitter/X: @RashmiJKumar- Melissa Pilewskie, MDAttending Breast Surgical Oncologist, Co-Director of the Weiser Family Center for Breast Cancer, Michigan MedicineTwitter/X: @MPilewskie- Stephanie Downs-Canner, MDAttending Breast Surgical Oncologist & Physician-Scientist, Memorial Sloan Kettering Cancer Center, Program Director of the Breast Surgical Oncology Fellowship Training ProgramTwitter/X: @SDownsCannerLearning Objectives: Define immunotherapy and immune checkpoint inhibition in breast cancer  Summarize current clinical indications and pivotal evidence for pembrolizumab in TNBC  Equip perioperative clinicians to identify and manage immune-related adverse events (irAEs) or side effects of immunotherapy.  Rationale for Immunotherapy in Breast Cancer ReviewSelecting Triple Negative Breast Cancer Patients for Immunotherapy: https://pubmed.ncbi.nlm.nih.gov/37714640/Landmark Clinical Trials Discussed in this Episode KEYNOTE-355: https://pubmed.ncbi.nlm.nih.gov/33232653/ KEYNOTE-522: https://pubmed.ncbi.nlm.nih.gov/33232642/ IMpassion130: https://pubmed.ncbi.nlm.nih.gov/30345906/ IMpassion131: https://pubmed.ncbi.nlm.nih.gov/33930478/ Assessment of Surgical Outcomes in patients receiving chemoimmunotherapySurgical outcomes after neoadjuvant chemoimmunotherapy in triple-negative breast cancer: https://pubmed.ncbi.nlm.nih.gov/38332314/Immune Related Adverse Events and Management Schneider BJ, et al. Management of immune-related adverse events: https://pubmed.ncbi.nlm.nih.gov/34724392/ Brahmer JR, et al. SITC clinical practice guideline: https://pubmed.ncbi.nlm.nih.gov/34177534/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewOBGYN Oral Board Review Coures: https://behindtheknife.org/course/obgyn-oral-board-reviewEPA Playbook: https://behindtheknife.org/course/epa-playbookSurgical Instrument Flashcards: https://behindtheknife.org/course/surgical-instrument-flashcardsABSITE Review: https://behindtheknife.org/course/absite-2026-exam-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Today, I'm joined by Jenny Duan, co-founder & CEO of Clair Health Launching in November, Clair's wrist-worn wearable leverages a multimodal sensor and female biology world model to unlock continuous, noninvasive hormone monitoring. In this episode, we discuss building the data infrastructure for women's health. We also cover: The perimenopause opportunity Designing a proprietary sensor stack Moving toward medical device status Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider  Website: https://wearclair.com/ Instagram: https://www.instagram.com/clair_health  - The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities. Fitt Talent: https://talent.fitt.co/Consulting: https://consulting.fitt.co/Investments: https://capital.fitt.co/ Chapters: (00:00) Introduction (01:30) Clair product overview (02:02) Wearable design and form factor (03:00) Women's health landscape (05:40) Hormone tracking solutions gap (06:36) Technology and sensors (08:00) Accuracy and calibration (09:15) Homeodynamic vs. homeostatic (11:30) Clinical applications (13:15) Perimenopause opportunity (14:50) Female founder experience (17:00) Fundraising and team building (20:00) Investor conversations (21:20) Demand signal and waitlist (22:00) Launch strategy (25:10) Healthcare integrations (27:45) Staying laser-focused (29:41) CEO daily priorities (31:20) Clinical trials and strategy (32:12) Consumer vs. medical balance (33:05) Voice AI and app experience (35:02) Where to find (35:54) Conclusion

Send us Fan MailIn this systematic review and meta-analysis, Nim and Adrianne dig into just how common brain injury really is in neonates with critical congenital heart disease. Pooling 31 studies spanning two decades, the authors found that nearly 70% of these babies show some form of ischemic brain injury, split roughly between pre-operative and post-operative timing. Counter to what most clinicians would predict, kids who went to surgery earlier (days 4-6) had higher rates of white matter injury than those who waited longer. MRI remained the most sensitive tool for picking up these lesions, well ahead of ultrasound or CT. But the data stops well short of proving these findings predict long-term outcomes, and Nim pushes back on the idea that an abnormal scan alone should steer decisions about whether to operate.----Prevalence of Ischemic Brain Injury in Neonates With Congenital Heart Disease: A Systematic Review and Meta-Analysis.Kim C, Chetan D, Kazazian V, Alzamil J, Chau V, Seed M, Miller SP, Selvanathan T.Neurology. 2026 Feb 10;106(3):e214569. doi: 10.1212/WNL.0000000000214569. Epub 2026 Jan 9.PMID: 41512205Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YQC865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 14, 2027.Redefining Interprofessional Care Paradigms in Gastrointestinal Stromal Tumors (GIST): Clinical "Take-Homes" for Established and Rapidly Emerging Evidence on TKIs Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Deciphera Pharmaceuticals, a member of ONO Pharma.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YFB865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Evolving Strategies in Testing and Treatment of MET-Altered NSCLC: Clinical Complexities and Real-World Practicalities In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AbbVie.Disclosure information is available at the beginning of the video presentation.

Skin cancer remains one of the most common cancers in the United States, making effective sun protection an important component of preventive care. This course reviews sunscreen best practices, common patient questions, and recent updates affecting sunscreen products, including the addition of a new active ingredient to the OTC sunscreen monograph. You will be better prepared to provide evidence-based recommendations on sunscreen selection, sun safety, and skin cancer prevention.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTKendall Guthrie, PharmD, BCACPDirector of Co-Curriculum/Clinical Professor,UMKC School of PharmacyGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: -  Compliance and licensure CE -  GameChangers Clinical Updates-  Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here.  CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current recommendations for sunscreen use and sun protection to reduce the risk of skin cancer.2. Explain pharmacist-relevant considerations for sunscreen selection, including formulation differences, active ingredients, and patient counseling.Rachel Maynard and [Speaker] have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-289-H01-P Initial release date: 7/27/2026Expiration date: 7/27/2029Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YFB865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Evolving Strategies in Testing and Treatment of MET-Altered NSCLC: Clinical Complexities and Real-World Practicalities In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AbbVie.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YQC865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 14, 2027.Redefining Interprofessional Care Paradigms in Gastrointestinal Stromal Tumors (GIST): Clinical "Take-Homes" for Established and Rapidly Emerging Evidence on TKIs Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Deciphera Pharmaceuticals, a member of ONO Pharma.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YQC865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 14, 2027.Redefining Interprofessional Care Paradigms in Gastrointestinal Stromal Tumors (GIST): Clinical "Take-Homes" for Established and Rapidly Emerging Evidence on TKIs Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Deciphera Pharmaceuticals, a member of ONO Pharma.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YFB865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Evolving Strategies in Testing and Treatment of MET-Altered NSCLC: Clinical Complexities and Real-World Practicalities In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AbbVie.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YQC865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 14, 2027.Redefining Interprofessional Care Paradigms in Gastrointestinal Stromal Tumors (GIST): Clinical "Take-Homes" for Established and Rapidly Emerging Evidence on TKIs Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Deciphera Pharmaceuticals, a member of ONO Pharma.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YFB865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Evolving Strategies in Testing and Treatment of MET-Altered NSCLC: Clinical Complexities and Real-World Practicalities In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AbbVie.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YFB865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Evolving Strategies in Testing and Treatment of MET-Altered NSCLC: Clinical Complexities and Real-World Practicalities In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AbbVie.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YQC865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 14, 2027.Redefining Interprofessional Care Paradigms in Gastrointestinal Stromal Tumors (GIST): Clinical "Take-Homes" for Established and Rapidly Emerging Evidence on TKIs Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Deciphera Pharmaceuticals, a member of ONO Pharma.Disclosure information is available at the beginning of the video presentation.

Coronoid & Radial Head Fractures: Tips, Pitfalls, and Surgical Pearls with Dr. Niloofar Dehghan Watch on Youtube: https://youtu.be/UtVdaEMrm_c  In this episode, I sit down with Dr. Niloofar Dehghan, a fellowship-trained orthopaedic trauma and upper extremity surgeon, to take a deep dive into the evaluation and management of coronoid fractures, radial head fractures, and complex elbow instability. Dr. Dehghan completed her orthopaedic surgery residency at the University of Toronto, followed by fellowship training in Orthopaedic Trauma and Upper Extremity Reconstruction at St. Michael's Hospital in Toronto and Lower Extremity Reconstruction. She also earned a Master of Science in Clinical Epidemiology and Health Care Research from the University of Toronto and currently serves as an Associate Clinical Professor at the University of Arizona. During our conversation, we discuss: How to evaluate coronoid and radial head fractures When a fracture can be treated nonoperatively versus when surgery is indicated The role of fracture morphology in treatment planning Terrible triad injuries and strategies to restore elbow stability Surgical pearls for fixation and reconstruction Common mistakes surgeons make—and how to avoid them Postoperative rehabilitation and preventing stiffness Clinical cases and practical take-home points applicable to everyday practice Whether you're an orthopaedic resident, fellow, practicing surgeon, physician assistant, or simply interested in elbow trauma, this episode is packed with evidence-based insights and real-world surgical experience that you can apply immediately. Connect with Dr. Niloofar Dehghan LinkedIn: linkedin.com/in/niloofar-dehghan Instagram: @dr_niloofar_dehghan Threads: @dr_niloofar_dehghan on Threads If you enjoyed this episode, please subscribe, leave a review, and share it with your colleagues. Your support helps us continue bringing leading experts in orthopaedic surgery to the podcast.

In his weekly clinical update, Daniel Griffin and Vincent Racaniello explore the source/not source of the national cyclospora outbreak, trust in the FDA to correctly identify the source, new screwworm, Legionnaires and cyclosporasis cases, the Ebola outbreak in the Congo and development of a novel vaccine and antiviral before Dr. Griffin deep dives into the measles outbreak including the new Pennsylvania dashboard, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, difference between high and standard dose influenza vaccines, how to access and pay for Paxlovid, where to go for answers about long COVID-19, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode How helpful is not up to date? CDC: cyclosporiasis Taylor Farms pulls Mexican Lettuce on Cyclospora Cases (Bloomberg) FDA retracts positive cyclospora test on Taylor Farms lettuce (NPR: WHYY) False-positive lab sample DOES NOT change the basis for FDA's ongoing outbreak investigation (X) FDA retracts test result but still links Taylor Farms lettuce to cyclosporiasis (Washington Post) Infectious Disease Outbreaks (Michigan: Health & Human Services) Cyclospora Infection (Cyclosporiasis) (NYC Health) Legionnaires' Disease (NYC Health) Chapter 8: Cooling Towers (NYC Health) You can verify ifa person is licensed on the New York State Office of the Professions website: (NSPE-NY) Board for global EHS Credentialing (American Board of Industrial Hygiene) Water treatment vendor (Association of Water Technologies) Cooling Towers: Information for Owners and Operators (NYC Health) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Ebola dashboard (ebola.fyi) EBOLA:The Democratic Republic of the Congo, 2026(WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo(WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) HAP's Latest News Pa. Launches New Measles Dashboard (Hospital + HealthSystem Association of Pennsylvania) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Measles(CDC: Measles Rubeola) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Influenza vaccine effectiveness against outpatient acute respiratory illness withlaboratory-confirmed influenza, United States, 2024–25 season (CID) Effect of high-dose versus standard-dose influenza vaccines on hospitalisation outcomes and mortality in older adults: a systematic review and meta-analysis (LANCET: Healthy Longevity) Weekly surveillance report: clift notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix (JID) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1342 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

This episode provides health system pharmacists with comprehensive, evidence-based information about rotavirus disease and vaccination. The discussion covers the historical burden of rotavirus disease, clinical complications, current CDC/ACIP vaccination recommendations, clinical management protocols, public health reporting requirements, and the pharmacist's role in addressing caregiver questions. This episode clarifies current vaccination guidelines and equips pharmacists with the knowledge to support optimal immunization practices within their health systems. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

On In The Market with Janet Parshall this week, former Air Force pilot, Lt. Col. Phil Cochran shared the spiritual lessons he learned in the cockpit of an F-16 fighter. National security expert Bill Gertz was back to speak about the communist influence efforts of Cuba attempts to infiltrate America and update us on the ongoing efforts of China to gain ultimate control of the world. As our nation celebrates 250 years of independence, Cynthia Scott, a member of America’s National Prayer Committee, reminded us of the men and women of faith who prayed this nation into existence. Clinical psychologist and mental health expert Dr. Linda Mintle explained how to slow down our anxiety and stress and how to find and walk God’s peace. As we end the week you are invited to join us for another exploration of the headlines through God perfect lens of truth.Become a Parshall Partner: http://moodyradio.org/donateto/inthemarket/partnersSee omnystudio.com/listener for privacy information.

Send us Fan MailWhat if communication were treated as a procedure, something we train for and get feedback on, just like an intubation?  In this episode of Neo News, Eli Cahan talks with Dr. Jessica Fry of Northwestern University and Lurie Children's Hospital about her NeoReviews piece, "Recognizing Communication as a Procedural Skill in Neonatology." Dr. Fry shares the personal loss that shaped her career, the ethical stakes of getting family communication right, and how trauma-informed care can guide something as simple as how we address parents on rounds. They discuss the critical first 48 hours after admission and how simulation-based training can build real skill over time. A candid look at a skill every NICU provider uses daily, and how we can all get better at it. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Physical Performance Show – Episode 382 Show Notes In this episode of The Physical Performance Show, host Brad Beer sits down with Pogo Physio's Tim Studley for Part 2 of their two-part mini-series on shin pain and tibial bone stress injuries. Having covered diagnosis and differentiation between MTSS and tibial bone stress injuries in Part 1, this episode shifts focus to management — mechanics, return-to-run programming, strength and conditioning, footwear, and terrain considerations for runners recovering from (or trying to prevent) tibial bone stress injury. Show Sponsor: Pillar Performance continues to lead the way in sports nutrition through micro-nutrition innovation, now expanding into the Performance Health range. One of their newest releases, Collagen Repair, was developed with Gelita Laboratories (Germany) using a clinically trialled collagen peptide (Tendofort) to support tendon and ligament health in conditions like hamstring tendinopathy, Achilles tendonitis, shin splints, and patellofemoral pain. Head to pillarperformance.shop (or thefeed.com for North American listeners) and use code PHYSICALPERFORMANCE for 15% off your first purchase. Pogo Physio also offers online Telehealth Consultations for endurance athletes managing bone, tendon, or joint issues — book online at pogophysio.com.au. Listen in as we delve into the following: Biomechanical vs. biological risk factors, and why running intensity matters more than mileage for bone Cadence, overstriding, and how a heel-strike pattern increases tibial loading Foot pressure distribution, lateralised loading, and how footwear/orthotics can help A case study: how cadence cueing, orthotics, heel raises, and calf strengthening resolved recurrent tibial bone stress injury Managing anterior tibial cortex injuries: why they're high-risk, slow to heal, and often need surgery Moving from time-based to symptom-led (optimal load) management for posterior-medial tibial bone stress injuries The five evidence-based criteria for returning to running after a tibial bone stress injury Why a 10% increase in pace can cut a bone's fatigue threshold by 50% Structuring intensity and volume in a return-to-run program to avoid a "double whammy" of risk Strength and conditioning phases: contralateral leg work, weight-bearing progressions, and pre-running plyometrics Clinical strength benchmarks for calf raises, leg press, hamstring curls, and hip abduction Footwear considerations: heel wedges, rocker-bottom shoes, and the debate around carbon plates Surface and terrain: why stiffer surfaces and flat terrain are preferred during return-to-run Treadmill running and its effect on distal loading What's next: an upcoming Q&A episode, and future instalments covering the femur, sacrum, tarsal bones, and calcaneus Quotes "Muscle loads bone." — Brad Beer "That runner doesn't need to be strong. They need to be uber strong." — Brad Beer, quoting tendon researcher Ebonie Rio "A 10% increase in pace reduces the fatigue threshold of a bone by 50%." — Brad Beer Timeline 00:00 – Introduction & sponsor: Pillar Performance 02:26 – Running mechanics and tibial bone stress injury risk 03:18 – Cadence, overstriding, and heel-strike patterns 05:43 – Foot pressure distribution and medial tibial bending 07:39 – Case study: footwear, orthotics, and cadence cueing 08:37 – Overview of bone stress injury management complexity 09:35 – Anterior tibial cortex injuries: high risk, slow healing, surgery 11:30 – Shift from time-based to symptom-led management 14:49 – Balancing speed of return with recurrence risk 15:48 – Five evidence-based return-to-run criteria (Sheeran & Reid, 2024) 18:11 – Why intensity is a greater risk factor than volume 20:35 – Strength and conditioning: matching capacity to running demands 22:29 – Three-phase strength progression: pre-, during-, and post-weight bearing 24:52 – Clinical strength benchmarks for return to running 26:16 – Return-to-run walking milestones and symptom monitoring 27:16 – Pain tolerance guidelines: the "any pain, stop" rule for bone 27:45 – Footwear considerations: heel wedges, rocker-bottom shoes, carbon plates 28:42 – Surface and terrain considerations 29:40 – Treadmill running and distal loading effects 30:39 – What's next: Q&A episode and future bone stress injury series 33:01 – Episode close & sponsor mentions THE TEAM: Join The Physical Performance Show LEARNINGS membership through weekly podcasts here: https://www.patreon.com/TPPShow Our goal is to get you back to your Physical Best. Find out more about Telehealth Consultations and book online at pogophysio.com.au. Your Hosts:

Kyle and Joe interview Rachel Turetzky & Douglas S. Wingate about their perspectives on the WilsonLeary 8 Circuit Model of consciousness. They recently released a CE approved program on Psychedelic Education Center to train therapists on this model and how to integrate the 8 Circuit Model into your clinical therapy practice. In this episode: Maybe Day and maybe logic: Honoring Robert Anton Wilson and learning to hold beliefs, models, and interpretations more lightly Reality tunnels: How biology, experience, culture, and conditioning filter our perception of reality Robert Anton Wilson's legacy: Guerrilla ontology, stand-up philosophy, Prometheus Rising, and using humor to destabilize rigid beliefs Timothy Leary beyond the caricature: His early work in psychology, the development of the Eight-Circuit Model, and the parts of his intellectual legacy that are often overlooked The first four circuits: Bodily safety, emotional territory, language and symbolic thinking, and social and relational conditioning The upper circuits: Sensory and somatic intelligence, metacognition, archetypal and transpersonal experience, and unitive states of consciousness Metaprogramming: Identifying the beliefs, imprints, and automatic patterns shaping our lives—and developing the capacity to revise them Circuit Zero and Stanislav Grof: Prenatal and perinatal experience, the basic perinatal matrices, and the lasting influence of early development Normalizing unusual experiences: Archetypal encounters, ancestral material, entities, out-of-body experiences, synchronicities, and other phenomena that conventional psychology may struggle to interpret Psychedelics and re-imprinting: How expanded states may loosen entrenched developmental patterns and create opportunities for psychological change Pleasure as therapeutic material: Anhedonia, chronic survival states, the "hedonic intelligence" of Circuit Five, and learning to experience joy without treating it as a distraction from the work Clinical applications: Using the model during psychedelic preparation to identify intentions, developmental imprints, and material that may emerge Medicine and dosage selection: How MDMA, ketamine, psilocybin, LSD, and 5-MeO-DMT may produce different experiences depending on the intention and dose Integration and verticality: Grounding expansive, archetypal, or unitive experiences through the body, emotions, relationships, and everyday life Chapel Perilous: Understanding destabilizing experiences, ontological shock, spiritual emergencies, and the process of reconstructing meaning afterward Beyond psychedelics: Connections with yoga, meditation, occult practice, Chinese medicine, chakra systems, and other psychospiritual traditions The new course: The structure of The Eight-Circuit Model of Consciousness: An Integrative Framework for Psychedelic-Assisted Therapy, including its 14 lessons, practical exercises, assessments, certification, and continuing-education options

"Access to care" sounds like something everyone should support.So why do we think it's become one of the most misleading phrases in pelvic health?In this episode, we argue that we've been solving the wrong problem.Because the goal isn't access to care.  The goal is access to quality care.We discuss: Why lowering the standard of care isn't the same as increasing access  The difference between access and quality  Why patients are still falling through the cracks despite having "access"  The six biggest opportunities to improve pelvic healthcare  Why raising standards—not lowering them—is how we truly help more people If our profession wants to serve more patients, the answer isn't diluting what makes pelvic health special.It's building more clinicians, better businesses, stronger education, and higher standards. About Nicole & Jesse CozeanPelvic health is hard. We want everyone in this field to have a joyful, impactful career. And for business owners to build something that truly works for them.

July 23, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: The Trump administration announces $5B+ for the Genesis Mission, a government-wide AI initiative uniting 15 agencies to accelerate scientific and drug discovery Garmin acquires TrainingPeaks and TrainHeroic, adding endurance and strength coaching to evolve from device maker into a full-stack performance platform Whoop names cardiologist Dr. Ami Bhatt as chief medical officer, adding clinical credibility ahead of an expected IPO as wearables take on health functions More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe  Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider  Reach out → insider@fitt.co 

As part of our virtual road trip around North America inspired by the 2026 World Cup, we're revisiting some of our most classic cases. This week we stop off in  Sacramento, to revisit on of the single most disturbing individuals we have ever covered Richard Chase - The Vampire of Sacramento. Clinical vampirism, terrifying delusions and paranoid schizophrenia. This week the girls enter the bloody world of their very first truly psychotic spree killer, Richard Trenton Chase. Join them as they follow his evolution from cat-murdering child, to drug-addicted teen, to blood-smeared twenty-something; unpicking the unbelievably shocking story of one of America's bloodiest killers.